EN9

(2R)-2-[(4-chlorophenyl)sulfonyl-[[2-fluoranyl-4-(1,2,4-oxadiazol-3-yl)phenyl]methyl]amino]-5,5,5-tris(fluoranyl)pentanamide


Toggle HydrogenToggle Labels

Chemical Component Summary

Name(2R)-2-[(4-chlorophenyl)sulfonyl-[[2-fluoranyl-4-(1,2,4-oxadiazol-3-yl)phenyl]methyl]amino]-5,5,5-tris(fluoranyl)pentanamide
Identifiers(2~{R})-2-[(4-chlorophenyl)sulfonyl-[[2-fluoranyl-4-(1,2,4-oxadiazol-3-yl)phenyl]methyl]amino]-5,5,5-tris(fluoranyl)pentanamide
FormulaC20 H17 Cl F4 N4 O4 S
Molecular Weight520.885
TypeNON-POLYMER
Isomeric SMILESc1cc(ccc1S(=O)(=O)N(Cc2ccc(cc2F)c3ncon3)[C@H](CCC(F)(F)F)C(=O)N)Cl
InChIInChI=1S/C20H17ClF4N4O4S/c21-14-3-5-15(6-4-14)34(31,32)29(17(18(26)30)7-8-20(23,24)25)10-13-2-1-12(9-16(13)22)19-27-11-33-28-19/h1-6,9,11,17H,7-8,10H2,(H2,26,30)/t17-/m1/s1
InChIKeyXEAOPVUAMONVLA-QGZVFWFLSA-N

Chemical Details

Formal Charge0
Atom Count51
Chiral Atom Count1
Bond Count53
Aromatic Bond Count17

Drug Info: DrugBank

DrugBank IDDB11893 
NameAvagacestat
Groups investigational
DescriptionAvagacestat has been investigated for the basic science and treatment of Alzheimer Disease.
SynonymsAvagacestat
Categories
  • Amides
  • Amyloid Precursor Protein Secretases, antagonists & inhibitors
  • Enzyme Inhibitors
  • Gamma Secretase Inhibitors and Modulators
  • Oxazoles
CAS number1146699-66-2

Related Resource References

Resource NameReference
PubChem 46883536
ChEMBL CHEMBL1090771